Best TWAS P=1.69e-15 · Best GWAS P=1.36e-13 conditioned to 0.35
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Subcutaneous | LINC00886 | 0.42 | 0.24 | enet | 28 | 0.38 | 1.7e-32 | -6.9 | -5.3 | 9.8e-08 | 0.35 | 0.11 | 0.89 | FALSE |
2 | GTEx | Artery Aorta | LINC00886 | 0.40 | 0.24 | lasso | 9 | 0.22 | 2.7e-12 | -6.9 | -6.6 | 3.8e-11 | 0.54 | 0.16 | 0.84 | FALSE |
3 | GTEx | Artery Tibial | TIPARP | 0.13 | 0.02 | enet | 17 | 0.05 | 8.2e-05 | -6.7 | -7.5 | 5.1e-14 | 0.71 | 0.01 | 0.98 | FALSE |
4 | GTEx | Artery Tibial | LINC00886 | 0.43 | 0.26 | enet | 59 | 0.42 | 4.2e-35 | -6.9 | -7.4 | 1.5e-13 | 0.59 | 0.11 | 0.89 | FALSE |
5 | GTEx | Breast Mammary Tissue (Male) | LINC00886 | 0.17 | 0.03 | enet | 4 | 0.04 | 4.4e-02 | -6.9 | -6.0 | 2.6e-09 | 0.60 | 0.06 | 0.19 | FALSE |
6 | GTEx | Colon Transverse | LINC00886 | 0.41 | 0.24 | lasso | 14 | 0.24 | 1.7e-11 | -6.9 | -5.3 | 8.8e-08 | 0.53 | 0.24 | 0.76 | FALSE |
7 | GTEx | Esophagus Muscularis | METTL15P1 | 0.10 | 0.03 | lasso | 2 | 0.02 | 1.8e-02 | -6.7 | -6.9 | 7.0e-12 | 0.68 | 0.16 | 0.72 | FALSE |
8 | GTEx | Heart Left Ventricle | LINC00886 | 0.25 | 0.08 | lasso | 10 | 0.07 | 1.5e-04 | -6.7 | -5.6 | 2.1e-08 | 0.49 | 0.25 | 0.51 | FALSE |
9 | GTEx | Nerve Tibial | LINC00886 | 0.30 | 0.14 | lasso | 16 | 0.16 | 8.4e-12 | -6.9 | -6.0 | 1.9e-09 | 0.52 | 0.12 | 0.88 | FALSE |
10 | GTEx | Pancreas | LINC00886 | 0.32 | 0.23 | enet | 25 | 0.26 | 3.1e-11 | -6.9 | -6.3 | 2.3e-10 | 0.56 | 0.24 | 0.75 | FALSE |
11 | GTEx | Testis | LINC00886 | 0.39 | 0.24 | lasso | 9 | 0.21 | 1.5e-09 | -6.9 | -5.8 | 7.0e-09 | 0.47 | 0.13 | 0.87 | FALSE |
12 | METSIM | Adipose | LEKR1 | 0.09 | 0.09 | lasso | 3 | 0.09 | 1.7e-13 | -7.3 | 7.2 | 5.9e-13 | -0.99 | 0.00 | 1.00 | FALSE |
13 | METSIM | Adipose | TIPARP | 0.07 | 0.08 | lasso | 4 | 0.08 | 6.3e-12 | -5.4 | -5.3 | 9.2e-08 | 0.03 | 1.00 | 0.00 | TRUE |
14 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | LEKR1 | 0.10 | 0.14 | lasso | 6 | 0.12 | 1.8e-10 | -7.3 | 7.4 | 1.3e-13 | -1.00 | 0.00 | 1.00 | FALSE |
15 | The Cancer Genome Atlas | Breast Invasive Carcinoma | LEKR1 | 0.13 | 0.16 | lasso | 5 | 0.15 | 3.6e-30 | -7.4 | 7.2 | 5.9e-13 | -1.00 | 0.00 | 1.00 | FALSE |
16 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | LEKR1 | 0.18 | 0.12 | enet | 8 | 0.10 | 9.2e-06 | -7.4 | 7.6 | 2.4e-14 | -0.99 | 0.00 | 1.00 | FALSE |
17 | The Cancer Genome Atlas | Colon Adenocarcinoma | LEKR1 | 0.16 | 0.12 | lasso | 2 | 0.09 | 5.2e-06 | -7.4 | 7.3 | 3.5e-13 | -1.00 | 0.00 | 1.00 | FALSE |
18 | The Cancer Genome Atlas | Esophageal Carcinoma | LEKR1 | 0.25 | 0.08 | blup | 112 | 0.18 | 2.0e-06 | -7.3 | 6.5 | 1.1e-10 | -0.80 | 0.01 | 0.97 | FALSE |
19 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | LEKR1 | 0.09 | 0.10 | lasso | 3 | 0.09 | 4.4e-10 | -7.3 | 7.5 | 5.6e-14 | -0.99 | 0.00 | 1.00 | FALSE |
20 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | LEKR1 | 0.22 | 0.18 | enet | 21 | 0.22 | 2.1e-24 | -6.9 | 7.2 | 7.6e-13 | -0.89 | 0.01 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | LEKR1 | 0.16 | 0.13 | lasso | 5 | 0.13 | 8.4e-08 | -7.4 | 7.4 | 1.8e-13 | -0.98 | 0.00 | 1.00 | FALSE |
22 | The Cancer Genome Atlas | Lung Adenocarcinoma | LEKR1 | 0.09 | 0.12 | lasso | 1 | 0.11 | 1.2e-12 | -7.4 | 7.4 | 1.4e-13 | -1.00 | 0.00 | 1.00 | FALSE |
23 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | LEKR1 | 0.12 | 0.07 | blup | 114 | 0.08 | 2.6e-09 | -6.9 | 6.4 | 1.4e-10 | -0.91 | 0.00 | 1.00 | FALSE |
24 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | LEKR1 | 0.23 | 0.27 | lasso | 2 | 0.26 | 1.7e-17 | -7.3 | 7.2 | 5.0e-13 | -0.99 | 0.00 | 1.00 | FALSE |
25 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | LEKR1 | 0.14 | 0.15 | lasso | 1 | 0.15 | 9.8e-07 | -7.4 | 7.4 | 1.4e-13 | -1.00 | 0.00 | 0.99 | FALSE |
26 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | LEKR1 | 0.27 | 0.07 | blup | 113 | 0.07 | 1.0e-03 | -7.3 | 5.3 | 1.2e-07 | -0.86 | 0.01 | 0.97 | FALSE |
27 | The Cancer Genome Atlas | Prostate Adenocarcinoma | LEKR1 | 0.20 | 0.19 | lasso | 5 | 0.19 | 2.6e-19 | -7.4 | 7.5 | 6.5e-14 | -0.99 | 0.00 | 1.00 | FALSE |
28 | The Cancer Genome Atlas | Rectum Adenocarcinoma | LEKR1 | 0.40 | 0.25 | lasso | 2 | 0.26 | 9.1e-07 | -6.9 | 6.9 | 6.2e-12 | -0.84 | 0.02 | 0.93 | FALSE |
29 | The Cancer Genome Atlas | Soft Tissue Sarcoma | LEKR1 | 0.15 | 0.04 | lasso | 6 | 0.09 | 6.9e-06 | -7.4 | 8.0 | 1.7e-15 | -0.85 | 0.01 | 0.99 | TRUE |
30 | The Cancer Genome Atlas | Stomach Adenocarcinoma | LEKR1 | 0.06 | 0.07 | lasso | 3 | 0.07 | 1.1e-05 | -6.9 | 7.5 | 5.2e-14 | -0.88 | 0.02 | 0.97 | FALSE |
31 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | LEKR1 | 0.12 | 0.03 | blup | 114 | 0.03 | 2.5e-02 | -6.7 | 5.6 | 2.7e-08 | -0.76 | 0.02 | 0.60 | FALSE |
32 | The Cancer Genome Atlas | Thyroid Carcinoma | LEKR1 | 0.24 | 0.33 | lasso | 8 | 0.37 | 9.5e-38 | -6.9 | 7.6 | 3.5e-14 | -0.95 | 0.01 | 0.99 | FALSE |
33 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | LEKR1 | 0.21 | 0.14 | lasso | 4 | 0.10 | 8.6e-04 | -7.4 | 7.4 | 1.4e-13 | -1.00 | 0.00 | 0.95 | FALSE |